Overview of CRISPR/Cas9 and Gene Editing

#WIE #medical #automation #robotics #Genetics

CRISPR/Cas9 and related protein:RNA complexes are Gene Editing enzymes that are revolutionizing biological research and also starting to enter the therapeutic realm.  A Cas9-based therapeutic strategy to treat sickle cell anemia received approval recently in the United Kingdom and is also being considered for FDA approval in the United States.  

In this presentation, I will give a broad introduction to enzymes used for Gene Editing, including Cas9, base editors, and prime editors.  This introduction is intended for both non-biologists and biologists,   including the role of computational analysis in understanding gene editing outcomes. 

  Date and Time




  • Date: 14 Dec 2023
  • Time: 06:30 PM to 08:00 PM
  • All times are (UTC-05:00) Eastern Time (US & Canada)
  • Add_To_Calendar_icon Add Event to Calendar
If you are not a robot, please complete the ReCAPTCHA to display virtual attendance info.
  • Contact Event Hosts
  • Starts 23 November 2023 08:34 AM
  • Ends 14 December 2023 07:00 PM
  • All times are (UTC-05:00) Eastern Time (US & Canada)
  • No Admission Charge


Dr. Pattanayak of Massachusetts General Hospital


Overview of CRISPR/Cas9 and Gene Editing


Dr. Vikram (MD/PhD Harvard University) is the Director of Histocompatibility (HLA) Laboratory at the Massachusetts General Hospital and an Instructor in Pathology, Harvard Medical School

You can learn more about his background and contributions through the following links. 

Mass General: https://www.massgeneral.org/doctors/20264/vikram-pattanayak

LinkedIn: https://www.linkedin.com/in/vikram-pattanayak-04299b111/

Google Scholar: https://scholar.google.com/citations?user=jlc25hYAAAAJ&hl=en